+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas



The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas



Annals of Hematology 87(12): 985-990



Platelet-derived growth factor receptor alpha (PDGFRA) is important in numerous malignancies and can serve as a target for therapeutic strategy. We aimed to assess the role of PDGFRA expression in mature T- and natural killer (NK)-cell lymphomas. We used immunohistochemistry to analyze PDGFRA expression in mature T- and NK-cell lymphomas in tissue samples from 50 patients. In positive samples, we then did a mutational analysis of the PDGFRA gene on exons 10, 12, 14, and 18. The relationship between PDGFRA expression and overall survival in mature T- and NK-cell lymphomas was statistically analyzed in the study. We analyzed PDGFRA expression in four subtypes: angioimmunoblastic T-cell lymphoma (3/8, 37.5%); anaplastic large cell lymphoma (5/7, 71.4%); NK/T-cell lymphoma, nasal type (9/12, 75%); and peripheral T-cell lymphoma, unspecified (PTCLu; 7/23, 30.4%). It was lower in PTCLu than in other subtypes (30.4% vs. 63%, p=0.022). PDGFRA expression was not related to PDGFRA gene mutation. Overall survival in mature T- and NK-cell lymphomas correlated significantly with disease subtypes and an international prognostic index but not PDGFRA expression. Our study showed that PDGFRA expression was different in mature T- and NK-cell lymphomas. PDGFRA expression in PTCLu was lower in the present study than in previous reports done in Western countries. It suggests that this disease is biologically distinct in different races (30.4% vs. 91-100%).

(PDF emailed within 0-6 h: $19.90)

Accession: 056339123

Download citation: RISBibTeXText

PMID: 18633616

DOI: 10.1007/s00277-008-0539-z


Related references

Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma. Archives of Pathology & Laboratory Medicine 131(2): 261-267, 2007

Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology 141(12): 2213-2220, 2016

Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas. Journal of Neurology, Neurosurgery, and Psychiatry 72(6): 782-787, 2002

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. American Journal of Pathology 175(1): 334-341, 2009

Prognostic significance of expression of platelet-derived endothelial cell growth factor in bladder cancer. Journal of Urology 157(4 SUPPL ): 340, 1997

IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression. Journal of Immunology 150(12): 5625-5632, 1993

Prognostic significance of platelet-derived growth factor-BB expression in human esophageal squamous cell carcinomas. Anticancer Research 27(4b): 2409-2414, 2007

Immunohistochemical examination of effects of kefir, koumiss and commercial probiotic capsules on platelet derived growth factor-c and platelet derived growth factor receptor-alpha expression in mouse liver and kidney. Biotechnic & Histochemistry 90(3): 190-196, 2015

Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma. Contemporary Oncology 17(2): 150-155, 2013

Immunohistochemistry analysis of platelet-derived growth factor A and B chains and platelet-derived growth factor alpha and beta receptor expression in benign prostatic hyperplasia and Gleason-graded human prostate adenocarcinomas. Modern Pathology 7(5): 549-554, 1994

Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer. International Journal of Urology 8(9): 478-482, 2001

Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma. American Journal of Clinical Pathology 120(1): 107-112, 2003

Inhibition of human natural killer cell activity by platelet derived growth factor ii. membrane binding studies effects of recombinant ifn alpha and il 2 and lack on effect of t cell and antibody dependent cellular cytotoxicity. Journal of Immunology 141(11): 4031-4038, 1988